ESC 365 - How useful are risk scores in determining bleeding risk and antithrombotic therapy duration after primary PCI?

ESC Professional Premium Access

How useful are risk scores in determining bleeding risk and antithrombotic therapy duration after primary PCI?

Session: Personalised management after primary PCI for ST elevation myocardial infarction: unresolved issues

Topic: ST-Elevation Myocardial Infarction (STEMI)

Speaker: Doctor R. Colleran (Dublin 7, IE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Roisin Colleran

Mater Private Network, Dublin 7 (Ireland)

5 presentations

0 follower

4 more presentations in this session

When to use a pharmaco-invasive approach rather than primary PCI

Speaker: Professor A. Kastrati (Munich, DE)

Should everyone receive complete revascularisation after primary PCI?

Speaker: Assistant Professor B. Stahli (Zurich, CH)

Should 12 months of dual antiplatelet therapy still be the default recommendation after primary PCI?

Speaker: Professor S. James (Uppsala, SE)

Personalised management after primary PCI for ST elevation myocardial infarction: unresolved issues - discussion

Access the full session

Personalised management after primary PCI for ST elevation myocardial infarction: unresolved issues

Speakers: Doctor R. Colleran, Professor A. Kastrati, Assistant Professor B. Stahli, Professor S. James

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources